Lexicon Pharmaceuticals LXRX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's operating lease liabilities?
- Lexicon Pharmaceuticals (LXRX) reported operating lease liabilities of $6.38M in Q1 2026.
- How has Lexicon Pharmaceuticals's operating lease liabilities changed year-over-year?
- Lexicon Pharmaceuticals's operating lease liabilities increased by 41.2% year-over-year, from $4.52M to $6.38M.
- What is the long-term trend for Lexicon Pharmaceuticals's operating lease liabilities?
- Over 3 years (2022 to 2025), Lexicon Pharmaceuticals's operating lease liabilities has grown at a 6.8% compound annual growth rate (CAGR), from $5.42M to $6.6M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.